Due to the fact that MR-proANP has the same role as BNP in the pathophysiology of HF and similar diagnostic and prognostic value, the hypothesis that it may be used in biomarker-guided therapy is worth testing (Table 1). The gene discussed is NPPA; the disease is hydrops fetalis.